TY - JOUR
T1 - Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
AU - Heilmann-Heimbach, Stefanie
AU - Herold, Christine
AU - Hochfeld, Lara M.
AU - Hillmer, Axel M.
AU - Nyholt, Dale R.
AU - Hecker, Julian
AU - Javed, Asif
AU - Chew, Elaine G Y
AU - Pechlivanis, Sonali
AU - Drichel, Dmitriy
AU - Heng, Xiu Ting
AU - Del Rosario, Ricardo C H
AU - Fier, Heide L.
AU - Paus, Ralf
AU - Rueedi, Rico
AU - Galesloot, Tessel E.
AU - Moebus, Susanne
AU - Anhalt, Thomas
AU - Prabhakar, Shyam
AU - Li, Rui
AU - Kanoni, Stavroula
AU - Papanikolaou, George
AU - Kutalik, Zoltán
AU - Deloukas, Panos
AU - Philpott, Michael P.
AU - Waeber, Gérard
AU - Spector, Tim D.
AU - Vollenweider, Peter
AU - Kiemeney, Lambertus A L M
AU - Dedoussis, George
AU - Richards, J. Brent
AU - Nothnagel, Michael
AU - Martin, Nicholas G.
AU - Becker, Tim
AU - Hinds, David A.
AU - Nöthen, Markus M.
PY - 2017
Y1 - 2017
N2 - Male-pattern baldness (MPB) is a common and highly heritable trait characterized by androgen-dependent, progressive hair loss from the scalp. Here, we carry out the largest GWAS meta-analysis of MPB to date, comprising 10,846 early-onset cases and 11,672 controls from eight independent cohorts. We identify 63 MPB-associated loci (P<5 × 10-8, METAL) of which 23 have not been reported previously. The 63 loci explain ∼39% of the phenotypic variance in MPB and highlight several plausible candidate genes (FGF5, IRF4, DKK2) and pathways (melatonin signalling, adipogenesis) that are likely to be implicated in the key-pathophysiological features of MPB and may represent promising targets for the development of novel therapeutic options. The data provide molecular evidence that rather than being an isolated trait, MPB shares a substantial biological basis with numerous other human phenotypes and may deserve evaluation as an early prognostic marker, for example, for prostate cancer, sudden cardiac arrest and neurodegenerative disorders.
AB - Male-pattern baldness (MPB) is a common and highly heritable trait characterized by androgen-dependent, progressive hair loss from the scalp. Here, we carry out the largest GWAS meta-analysis of MPB to date, comprising 10,846 early-onset cases and 11,672 controls from eight independent cohorts. We identify 63 MPB-associated loci (P<5 × 10-8, METAL) of which 23 have not been reported previously. The 63 loci explain ∼39% of the phenotypic variance in MPB and highlight several plausible candidate genes (FGF5, IRF4, DKK2) and pathways (melatonin signalling, adipogenesis) that are likely to be implicated in the key-pathophysiological features of MPB and may represent promising targets for the development of novel therapeutic options. The data provide molecular evidence that rather than being an isolated trait, MPB shares a substantial biological basis with numerous other human phenotypes and may deserve evaluation as an early prognostic marker, for example, for prostate cancer, sudden cardiac arrest and neurodegenerative disorders.
UR - http://www.scopus.com/inward/record.url?scp=85014867125&partnerID=8YFLogxK
U2 - 10.1038/ncomms14694
DO - 10.1038/ncomms14694
M3 - Article
AN - SCOPUS:85014867125
SN - 2041-1723
VL - 8
JO - Nature Communications
JF - Nature Communications
M1 - 14694
ER -